The expression of lipoprotein lipase (LPL) mRNA and the LPL activity were studied in macrophages (CD14 positive) from human atherosclerotic tissue. Macrophages were isolated after collagenase digestion by immunomagnetic isolation. About 90% of the cells were foam cells with oil red 0 positive lipid droplets. To analyze the mRNA expression, PCR with specific primers for LPL was used. Arterial macrophages were analyzed directly after isolation and the data showed low expression of LPL mRNA when compared with monocyte-derived macrophages. To induce the expression of LPL mRNA in macrophages, PMA was used. When incubating arterial macrophages with PMA for 24 h we could not detect any increase in LPL mRNA levels. Similarly, the cells secreted very small amounts of LPL even after PMA stimulation. In conclusion, these studies show a very low expression of LPL mRNA in the CD14-positive macrophage-derived foam cells isolated from human atherosclerotic tissue. These data suggest that the CD14-positive cells are a subpopulation of foam cells that express low levels of lipoprotein lipase, and the lipid content could be a major factor for downregulation of LPL. However, the cells were isolated from advanced atherosclerotic lesions, and these findings may not reflect the situation in early fatty streaks. (J. Clin. Invest. 1993. 92:1759-1765
Introduction
Lipid laden cells, foam cells, are a hallmark ofthe early atherosclerotic lesions. Most of these cells seem to be derived from macrophages ( 1) . Macrophages are best known for their phagocytotic activity but are also secreting cells that produce several biologically active substances such as growth factors, cytokines, and reactive oxygen intermediates. The exact mechanism for foam cell formation has not been settled. Macrophages do not become foam cells when incubated with native LDL but incubation with hypertriglyceridemic VLDL or modified (oxidized, acetylated) LDL has been shown to result in foam cell formation in vitro (2) (3) (4) . Lipoprotein lipase (LPL)' is responsible for the catabolism of triglyceride-rich lipoproteins, i.e., chylomicrons and VLDLs. LPL enzyme activity has been found in the intima oflarger arteries in experimental atherosclerosis (5, 6) . LPL could create remnants locally in the tissue and increase the cholesterol deposition in the arterial wall. In agreement, studies by Lindquist et al. (7) suggest that triglyceride-rich lipoproteins may contribute to foam cell formation through the local degradation of lipoproteins by lipoprotein lipase, and to the uptake ofremnant particles into macrophages. Aviram et al. (8) demonstrated that LPL also can modify LDL so that it is taken up more avidly by cultured macrophages. Another mechanism is proposed by Beisiegel et al. (9) . They show that lipoprotein lipase enhances the binding of chylomicrons and ,B-VLDL to cells via the LDL receptor-related protein, which could be a mechanism for foam cell formation. In vitro studies show secretion of LPL in monocytederived macrophages (10) , mouse peritoneal macrophages, or monocyte-derived cell lines (1 1-14) . In immunohistochemical studies on human plaques Jonasson et al. (15) found no LPL associated with CD 14-positive cells. On the other hand, protein was observed in relation to smooth muscle cells. Recently Yla-Herttuala et al. ( 16) found, by in situ hybridization and immunocytochemistry, that a subfraction oflesion macrophages detected with a mAb against human macrophages (HAM-56) and smooth muscle cells in human and rabbit atherosclerotic aorta expressed LPL mRNA. O'Brien et al. (17) demonstrated that macrophage-derived foam cells (HAM-56 positive) rather than smooth muscle cells are the primary cellular source of LPL, detected by in situ hybridization, in human coronary plaques. Thus, data are to some extent conflicting and the role of LPL in atherosclerotic tissue is not clarified.
In the present study we analyze the expression of mRNA for lipoprotein lipase and secretion of the enzyme in macrophage (CD 14-positive) -derived foam cells from human atherosclerotic tissue at basal levels, as well as the possibility to induce synthesis and secretion.
Methods
Isolation ofcellsfrom tissue. Atherosclerotic aortic tissue was obtained from abdominal aorta (n = 9) and femoral arteries (n = 2) from patients (age 69-78 yr) undergoing surgery, due to aortic aneurysm or intermittent claudication. The specimens ofhuman atherosclerotic tissue displayed large variation in morphology, with severe atherosclerosis including calcification and thrombosis. After excision, the biopsies were immediately transferred to a 50-ml test tube containing HBSS. Small segments from the tissue specimens were fixed in 4% paraformaldehyde and paraffin-embedded for histological characterization. The adventitia was removed and intima media preparations were used for cell isolation. Intima media, 0.5-4. l-g tissue wet wt, was minced and digested with collagenase solution as previously described ( 18) . Isolated cells were suspended in medium RPMI 1640, supplemented with 1% BSA, and the cell suspension was kept on a slurry of ice and water after isolation.
This study was approved by the Ethics Committee of Research of the University of Gothenburg, Sweden.
Immunomagnetic (IM) fractionation of macrophages. Macrophages were isolated by using monoclonal antibodies and magnetic microspheres as described ( 19) . Briefly, the heterogeneous cell suspension was preincubated with uncoated dynabeads (Dynal AS, Oslo, Norway) for 10 min to get rid of collagen and elastin fibers. The cell suspension was then incubated with a mAb, anti-Leu-M3 (BectonDickinson and Co., Sunnyvale, CA) that recognizes the CD 14 antigen present on human macrophages. Anti-HLA-DR and anti-Leukocyte CD45 antibodies were also from (Becton-Dickinson and Co. 35 ,000 rpm. The following oligonucleotide primers for LPL were synthesized on a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) 5'-GAGATTTCT-CTGTATGGCACC-3' and 5'-CTGCAAATGAGACACTTTCTC-3'. The 5'-primer spanned the junction of the first two exons and the 3 '-primer spanned the junction ofthe next two exons for LPL (22) . For comparison we also amplified mRNA for IL-1j3, using the primers described by Wang et al. (23) . The 5'-primer was labeled in the 5'-end with 32P-gamma-ATP using polynucleotide kinase. RNA was reversed, transcribed together with an internal standard (AW 108) into cDNA, and the cDNA was then amplified by PCR. AW108 is a synthetic cRNA that contains 5' primers of 12 target mRNAs followed by the complementary sequences of the 3' primers. Quantitative analysis was performed using the PCR as described by Wang et al. (23) using a Gene Amp RNA PCR Kit (Perkin-Elmer Cetus Corp. Norwalk, CT). Briefly, the reverse transcription mixture containing 1 ng total cellular RNA from HMDM up to 100 ng total RNA from tissue macrophages corresponding to 5 X 102-5 X I04 cells, 1 X 104-1 X I05 molecules of AW108 cRNA, and random hexamer primer were incubated at room temperature for 10 min, 42°C for 15 min, heated to 99°C for 5 min, and then in 5°C for 5 min. After reverse transcription, serial 1:2 or 1:3 dilutions of the cDNA mixture were amplified by using the 3'-primer with the 32P-labeled 5'-primer. The PCR amplification protocol involved denaturation at 950C for 2 min in cycle 1, followed by 950C for 1 min, annealing at 60C for 1 min and extension at 60C for 7 min in 35 cycles for the analysis ofmRNA for LPL. All incubations were done in a Perkin-Elmer Cetus DNA Thermal Cycler. The PCR products were then separated on a 4% Nusieve GTG agarose gel (FMC Bioproducts Corp., Rockland, ME). 10 Ml of each PCR reaction mixture was electrophoresed with 10 Ml from a PCR reaction mixture without a radioactive primer. The electrophoresis was run for more than 5 h and visualized with ethidium bromide (E. Merck AG Darmstadt, Germany). Appropriate bands were cut out from the gel and melted, and the radioactivity was determined by liquid scintillation counting. The amounts of radioactivity recovered from the excised gel bands were plotted against the template concentrations.
Induction of macrophage differentiation with PMA. The IM isolated cells were resuspended in medium RPMI 1640 containing 10% Lipid analyses. Lipids were extracted from the arterial macrophages with hexane/isopropanol (3:2, vol/vol). The sample was applied on a quartz rod coated with silica gel, Chromarod S111 (NewmanHowells, Winchester, Hampshire, UK). Separation of lipids was performed with the use oftwo sequential solvents: hexane/ethyl ether (9:1 vol/vol), hexane/ethyl ether/acetic acid (72:18:1). After each solvent, FID was used to separate and quantify the lipids. The measurements were performed on latroscan TH-10 MK2 (Newman-Howells), and signals were integrated on a Hewlett-Packard computer. Quantification of cholesterol ester, triglycerides, and free cholesterol was made by standard comparison.
Results
Characterization oftissue macrophages. A photomicrograph of a hematoxylin-eosin stained section from one ofthe atherosclerotic lesions included in the study is shown in Fig. 1 combination of TLC and FID (25) . In Table I the concentration of lipids is shown for CD 14-positive cells isolated from 11 specimens of human atherosclerotic aorta. The results show accumulation of cholesterol ester, free cholesterol, and triglycerides in these cells.
Preparation and analysis ofRNA. To show the expression of mRNA in human cells, RNA was isolated from monocytederived macrophages and from macrophage-derived foam cells (CD 14-positive) from human atherosclerotic tissue. After reverse transcription, cDNA was amplified by PCR. We have used the AW108 internal standard to determine the amount of LPL mRNA in these cells. For quantification ofmRNA it is of importance that the amplification curves are parallel for the standard and the target mRNA. The efficiency of the amplifi- 35 cycles. An example of PCR products of LPL mRNA from macrophages and the internal standard in serial 1:3 dilutions of the cDNA mixture is shown in Fig. 2 . Reaction products were resolved by gel electrophoresis and visualized by ethidium bromide staining. The size ofthe LPL PCR product from AW108 cRNA is 300 bp and can be easily separated from the target mRNA PCR product, which has a size of 277 bp, for LPL. The amounts of radioactivity recovered from the excised gel bands were plotted against the template concentrations. As shown in Fig. 3 , RNA from 2,000 arterial macrophages and 1,000 molecules of AWl08 cRNA gave the same amounts of LPL PCR product, which gives 0. Figure 3 . Quantitative analysis of LPL mRNA levels in macrophages isolated from human atherosclerotic aorta. After separation of the PCR products with agarose gel electrophoresis the bands were cut out and radioactivity was determined by liquid scintillation counting. The variable template concentrations of the internal standard AW 108 cRNA (A) and the number of macrophages (o) were plotted against the radioactivity of their PCR products. Induction of LPL mRNA and LPL activity by PMA. To examine ifthe downregulated expression of LPL mRNA in the arterial macrophages was reversible, the induction of LPL production with PMA was studied. PMA have been shown to modulate differentiation of macrophages and increase LPL secretion ( 14) . LPL mRNA levels were quantitated after culturing of the IM isolated cells with PMA. In one experiment, arterial macrophages were incubated for 6 h with PMA. No change was observed in mRNA levels, 0.4 LPL mRNA molecules/cell vs. 0.2 LPL mRNA molecules/cell in the controls, without PMA. After 12 h of incubation with PMA, the mRNA levels were 0.3 LPL mRNA molecules/cell, compared to 0.1 molecules/cell without PMA (n = 2). When incubating arterial macrophages with PMA for 24 h, we could not detect any increase in LPL mRNA levels as compared to control cultures, for which 1.0 and 1.6 LPL mRNA molecules/cell were obtained, respectively (Table III) . To evaluate the effect of PMA in cultured monocyte-derived macrophages, RNA was isolated after induction of cells with PMA. Induction of LPL mRNA expression appeared after 6 h incubation ofHMDM with PMA. After 12 h of incubation with PMA the LPL expression reached a maximum, 10,937 LPL mRNA molecules/cell as compared to 675 molecules/cell without PMA (mean value, n = 2). In five experiments a 24-h treatment of the HMDM with PMA increased the levels ofLPL mRNA almost twofold (Table III) . In one experiment, we isolated CD 14, CD45 and HLA-DR positive cells from the same HMDM. LPL mRNA levels were nine times higher in CD 45-positive cells and 6.5 times higher in HLA-DR positive cells compared with CD 14-positive cells (Table IV) . This suggests that macrophages that express the CD 14 antigen are a subpopulation of cells that express lower levels of LPL mRNA. To evaluate if culturing of cells with beads changed LPL expression, the CD 14, CD45, and HLA-DR positive cells were cultured with or without PMA for 24 h, after which LPL mRNA expression was measured. The beads The arterial macrophages (Arterial M), HMDM, and leu-M3 positive cells isolated from HMDM (HMDM CD 14) were grown in either the presence or absence of 10 nM PMA for 24 h before RNA extraction and quantification with PCR. LPL mRNA molecules/cell is based on viable cells as judged by trypan blue staining. Data represent mean value oftwo experiments from arterial macrophages, and of five experiments from HMDM (mean±SD), and mean value of two experiments from HMDM CD 14.
were still present and attached to the cells during the culture experiments. Culturing with beads increased the LPL mRNA. The LPL mRNA expression in CD14-positive cells increased from 31 to 328 LPL mRNA molecules per cell after incubation with PMA (Table IV) . These results strongly suggest that the mRNA for LPL in macrophages isolated from human atherosclerotic aorta could not be induced with PMA, while a 10-fold increase in mRNA was seen in CD 14-positive HMDM. To rule out that the failure of tissue macrophages to respond to PMA was due to collagenase treatment, control experiments were performed in which HMDM were treated with collagenase before immunomagnetic isolation and induction with PMA. A 24-h treatment with PMA showed a ninefold increase of the LPL mRNA expression in the CD 14-positive cells, compared with collagenase-treated cells not exposed to PMA. Thus, the ability of CD 14-positive cells to respond to PMA was not affected by collagenase treatment. We also explored the secretion of LPL from CD 14-positive foam cells and HMDM. For that purpose, cells were cultured 6, 12, and 24 h with or without PMA, heparin was added, and the medium was collected and assayed for the heparin-releasable LPL activity. As shown in Table V , no detectable induction of LPL activity was seen in arterial macrophages. Low activity was seen in arterial macrophages after 6-h and after 12-h stimu- activity was seen after 6-h incubation with PMA; however, the LPL activity was 40-fold higher than in arterial macrophages. A 3.5-fold increase was detected after 12 h of incubation with PMA. In HMDM, the LPL activity increased from 1.14 to 2.94 mU/ 106 cells after a 24-h treatment with 10 nM PMA.
In conclusion, the data are consistent with the observed low levels of LPL mRNA in CD 14-positive arterial macrophages. LPL activity was low in noninduced as well as in induced cells. In HMDM, treatment with PMA for 24 h resulted in -2.5-fold increase in LPL activity.
Discussion
In this study we show that CD 14-positive macrophage-derived foam cells isolated from human atherosclerotic aorta express very low levels of mRNA for LPL, and the lipolytic activity of secreted LPL is extremely low. The observations on tissue-derived cells were compared with studies on HMDM. These data suggest that within the blood monocyte population CD14-positive cells may represent a subpopulation with lower expression of LPL. However, even in these cells the expression of LPL mRNA was about tenfold higher than that for tissue-derived cells. Furthermore, the CD 14-positive HMDM could be induced to about a 10-fold increase in LPL mRNA after incubation with PMA. These observations suggest that the low level of LPL mRNA and the lack of response to PMA is not due to downregulation or degradation of mRNA during the isolation procedure or during co-culture with magnetic beads (but does not rule it out). Stray et al. (26) (28) (29) (30) . The regulation of LPL by cytokines is complex, depending on the cell system that is used. Treatment with LPS lowered both LPL activity and LPL mRNA in HMDM, but TNF had no effect (28) . However, mouse peritoneal macrophages were shown to respond to TNF with a reduction in LPL activity (29) . In heart cell cultures the suppression of LPL activity by LPS was mediated by TNF (30). Querfeld et al. (31 ) have shown that IFN-,y and IL-l inhibit production of LPL by HMDM. IL-l suppresses LPL activity, but not expression of LPL mRNA in rat heart cells (32). We have not found any studies in the literature about the effect of IL-l on the expression of LPL mRNA in macrophages. Activated macrophages produce TNF and IL-1, but only IL-l has been shown to reduce LPL activity in HMDM. We have detected mRNA for IL-I in macrophages isolated from human lesions (not shown). IFN is an activator of macrophages. Jonasson et al. (33) have demonstrated that IFN-y suppressed synthesis and secretion of LPL by macrophages at IFN doses that upregulated expression of the activation marker HLA-DR. We have in earlier studies showed that most of the isolated macrophage-derived foam cells also expressed HLA-DR ( 19) . Activated T lymphocytes are present in the atherosclerotic plaque, and activated T cells produce IFN-y (for review see reference 34). In human macrophages, treatment with IFN reduced LPL mRNA along with medium LPL activity, suggesting that the inhibitory effects occur at the level of transcription or mRNA stabilization (30) . Therefore, the downregulation of LPL in arterial macrophages may be explained by a local production of IFN and IL-1 in the lesion.
Addition of PMA to cells had an augmenting effect on LPL secretion by macrophages in vitro ( 14, 34) . This is in agreement with our results. When monocyte-derived macrophages as well as CD 14-positive HMDM were incubated with PMA, the LPL mRNA expression was increased. In contrast, PMA had no effect on CD 14-positive macrophages isolated from atherosclerotic aorta; no change was observed in LPL mRNA levels or in LPL activity. It has been observed that the LPL expression increased when monocytes differentiate into macrophages, and when promonocytic cell lines, such as THP-1 cells, are stimulated by phorbol esters (35) , suggesting that LPL expression is linked to the differentiation, rather than to activation of the cells. Because differentiated cells express high LPL activity in vitro, and mature and quiescent cells show suppressed activity (13, 14) , it might be speculated that newly recruited monocytes in growing plaques express high levels of LPL, and that the activity is later suppressed as the cells become foam cells. It has recently been shown by Sofer et al. (36) that accumulation oftriglycerides decreased the LPL secretion in a dose-dependent manner in macrophages. It is possible that the suppressed LPL expression found in this study is due to triglyceride accumulation, since CD 14-positive cells from human aorta contained high levels of triglycerides as well as free cholesterol and cholesterol ester. Further investigation will be required to assess the role of LPL expression in lipid loaded macrophages, and in macrophages in different states of activation in human atherosclerotic tissue.
In conclusion, these studies show a very low expression of LPL mRNA in the CD 14-positive macrophage-derived foam cells isolated from human atherosclerotic tissue. The low LPL activity or the expression of LPL mRNA could not be induced with PMA to the levels found in HMDM. These data suggest that the CD 14-positive cells are a subpopulation of foam cells that express low levels of lipoprotein lipase, and the cell lipid content could be a major factor for downregulation of LPL.
